714 related articles for article (PubMed ID: 16293877)
1. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer.
Kuhl CK; Schrading S; Leutner CC; Morakkabati-Spitz N; Wardelmann E; Fimmers R; Kuhn W; Schild HH
J Clin Oncol; 2005 Nov; 23(33):8469-76. PubMed ID: 16293877
[TBL] [Abstract][Full Text] [Related]
2. Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial.
Kuhl C; Weigel S; Schrading S; Arand B; Bieling H; König R; Tombach B; Leutner C; Rieber-Brambs A; Nordhoff D; Heindel W; Reiser M; Schild HH
J Clin Oncol; 2010 Mar; 28(9):1450-7. PubMed ID: 20177029
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging of the breast improves detection of invasive cancer, preinvasive cancer, and premalignant lesions during surveillance of women at high risk for breast cancer.
Riedl CC; Ponhold L; Flöry D; Weber M; Kroiss R; Wagner T; Fuchsjäger M; Helbich TH
Clin Cancer Res; 2007 Oct; 13(20):6144-52. PubMed ID: 17947480
[TBL] [Abstract][Full Text] [Related]
4. [The "EVA" Trial: Evaluation of the Efficacy of Diagnostic Methods (Mammography, Ultrasound, MRI) in the secondary and tertiary prevention of familial breast cancer. Preliminary results after the first half of the study period].
Kuhl CK; Schrading S; Weigel S; Nüssle-Kügele K; Sittek H; Arand B; Morakkabati N; Leutner C; Tombach B; Nordhoff D; Perlet C; Rieber A; Heindel W; Brambs HJ; Schild H
Rofo; 2005 Jun; 177(6):818-27. PubMed ID: 15902631
[TBL] [Abstract][Full Text] [Related]
5. Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition.
Kriege M; Brekelmans CT; Boetes C; Muller SH; Zonderland HM; Obdeijn IM; Manoliu RA; Kok T; Rutgers EJ; de Koning HJ; Klijn JG;
Cancer; 2006 Jun; 106(11):2318-26. PubMed ID: 16615112
[TBL] [Abstract][Full Text] [Related]
6. High-risk screening: multi-modality surveillance of women at high risk for breast cancer (proven or suspected carriers of a breast cancer susceptibility gene).
Kuhl CK
J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):103-6. PubMed ID: 12585663
[TBL] [Abstract][Full Text] [Related]
7. Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results.
Kuhl CK; Schmutzler RK; Leutner CC; Kempe A; Wardelmann E; Hocke A; Maringa M; Pfeifer U; Krebs D; Schild HH
Radiology; 2000 Apr; 215(1):267-79. PubMed ID: 10751498
[TBL] [Abstract][Full Text] [Related]
8. The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk.
Podo F; Sardanelli F; Canese R; D'Agnolo G; Natali PG; Crecco M; Grandinetti ML; Musumeci R; Trecate G; Bergonzi S; De Simone T; Costa C; Pasini B; Manuokian S; Spatti GB; Vergnaghi D; Morassut S; Boiocchi M; Dolcetti R; Viel A; De Giacomi C; Veronesi A; Coran F; Silingardi V; Turchett D; Cortesi L; De Santis M; Federico M; Romagnoli R; Ferrari S; Bevilacqua G; Bartolozzi C; Caligo MA; Cilotti A; Marini C; Cirillo S; Marra V; Martincich L; Contegiacomo A; Pensabene M; Capuano I; Burgazzi GB; Petrillo A; Bonomo L; Carriero A; Mariani-Costantini R; Battista P; Cama A; Palca G; Di Maggio C; D'Andrea E; Bazzocchi M; Francescutti GE; Zuiani C; Londero V; Zunnui I; Gustavino C; Centurioni MG; Iozzelli A; Panizza P; Del Maschio A
J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):115-24. PubMed ID: 12585665
[TBL] [Abstract][Full Text] [Related]
9. Breast magnetic resonance image screening and ductal lavage in women at high genetic risk for breast carcinoma.
Hartman AR; Daniel BL; Kurian AW; Mills MA; Nowels KW; Dirbas FM; Kingham KE; Chun NM; Herfkens RJ; Ford JM; Plevritis SK
Cancer; 2004 Feb; 100(3):479-89. PubMed ID: 14745863
[TBL] [Abstract][Full Text] [Related]
10. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging.
Lehman CD; Blume JD; Weatherall P; Thickman D; Hylton N; Warner E; Pisano E; Schnitt SJ; Gatsonis C; Schnall M; DeAngelis GA; Stomper P; Rosen EL; O'Loughlin M; Harms S; Bluemke DA;
Cancer; 2005 May; 103(9):1898-905. PubMed ID: 15800894
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
[TBL] [Abstract][Full Text] [Related]
12. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination.
Warner E; Plewes DB; Hill KA; Causer PA; Zubovits JT; Jong RA; Cutrara MR; DeBoer G; Yaffe MJ; Messner SJ; Meschino WS; Piron CA; Narod SA
JAMA; 2004 Sep; 292(11):1317-25. PubMed ID: 15367553
[TBL] [Abstract][Full Text] [Related]
13. The challenge of imaging dense breast parenchyma: is magnetic resonance mammography the technique of choice? A comparative study with x-ray mammography and whole-breast ultrasound.
Pediconi F; Catalano C; Roselli A; Dominelli V; Cagioli S; Karatasiou A; Pronio A; Kirchin MA; Passariello R
Invest Radiol; 2009 Jul; 44(7):412-21. PubMed ID: 19448554
[TBL] [Abstract][Full Text] [Related]
14. MRI and mammography surveillance of women at increased risk for breast cancer: recommendations using an evidence-based approach.
Granader EJ; Dwamena B; Carlos RC
Acad Radiol; 2008 Dec; 15(12):1590-5. PubMed ID: 19000876
[TBL] [Abstract][Full Text] [Related]
15. The role of magnetic resonance imaging in screening women at high risk of breast cancer.
Warner E
Top Magn Reson Imaging; 2008 Jun; 19(3):163-9. PubMed ID: 18941396
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of screening with annual magnetic resonance imaging and mammography: results of the initial screen from the ontario high risk breast screening program.
Chiarelli AM; Prummel MV; Muradali D; Majpruz V; Horgan M; Carroll JC; Eisen A; Meschino WS; Shumak RS; Warner E; Rabeneck L
J Clin Oncol; 2014 Jul; 32(21):2224-30. PubMed ID: 24934793
[TBL] [Abstract][Full Text] [Related]
17. MR imaging for surveillance of women at high familial risk for breast cancer.
Kuhl CK
Magn Reson Imaging Clin N Am; 2006 Aug; 14(3):391-402, vii. PubMed ID: 17098180
[TBL] [Abstract][Full Text] [Related]
18. Improvement in DCIS detection rates by MRI over time in a high-risk breast screening study.
Warner E; Causer PA; Wong JW; Wright FC; Jong RA; Hill KA; Messner SJ; Yaffe MJ; Narod SA; Plewes DB
Breast J; 2011; 17(1):9-17. PubMed ID: 21251121
[TBL] [Abstract][Full Text] [Related]
19. Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the high breast cancer risk italian 1 study): final results.
Sardanelli F; Podo F; Santoro F; Manoukian S; Bergonzi S; Trecate G; Vergnaghi D; Federico M; Cortesi L; Corcione S; Morassut S; Di Maggio C; Cilotti A; Martincich L; Calabrese M; Zuiani C; Preda L; Bonanni B; Carbonaro LA; Contegiacomo A; Panizza P; Di Cesare E; Savarese A; Crecco M; Turchetti D; Tonutti M; Belli P; Maschio AD;
Invest Radiol; 2011 Feb; 46(2):94-105. PubMed ID: 21139507
[TBL] [Abstract][Full Text] [Related]
20. MRI screening in a clinic population with a family history of breast cancer.
Yu J; Park A; Morris E; Liberman L; Borgen PI; King TA
Ann Surg Oncol; 2008 Feb; 15(2):452-61. PubMed ID: 18026801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
